Timber Pharmaceuticals Announces All CONTROL Study Sites Open and Enrolling Patients with Moderate to Severe Congenital Ichthyosis
Stock Information for Timber Pharmaceuticals Inc Com (New)
Loading
Please wait while we load your information from QuoteMedia.